Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Schirmer, M; Dejaco, C; Dasgupta, B; Matteson, EL.
Polymyalgia rheumatica: strategies for efficient practice and quality assurance.
Rheumatol Int. 2015; 35(11):1781-1789
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Dejaco Christian

Dimensions Citations:

Plum Analytics:
Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease in persons over the age of 50 years. There are many diseases which mimic PMR, for which reason a careful diagnostic approach is required. While it is thought to be exquisitely responsive to glucocorticosteroid therapy, many patients respond incompletely and/or develop serious side effects over the protracted disease course. Improved methods for classification and disease assessment together with standardized treatment approaches and outcome assessments can serve to improve the care of patients with this disease.
Find related publications in this database (using NLM MeSH Indexing)
Algorithms -
Critical Pathways - standards
Decision Support Techniques -
Glucocorticoids - adverse effects
Glucocorticoids - therapeutic use
Health Services Research -
Humans -
Polymyalgia Rheumatica - classification
Polymyalgia Rheumatica - diagnosis
Polymyalgia Rheumatica - drug therapy
Polymyalgia Rheumatica - epidemiology
Predictive Value of Tests -
Quality Assurance, Health Care - standards
Quality Improvement - standards
Quality Indicators, Health Care - standards
Rheumatology - standards
Risk Factors -
Treatment Outcome -

Find related publications in this database (Keywords)
Polymyalgia rheumatica
Quality measures
Classification criteria
© Meduni Graz Impressum